1.
Basal cell adenocarcinoma of the supraglottic larynx: treatment of recurrent disease with tamoxifen.
Rare Tumors
; 3(4): e55, 2011 Oct 21.
Article
in English
| MEDLINE
| ID: mdl-22355510
ABSTRACT
At the age of 83, a woman presented with an extremely rare cancer, basal cell adenocarcinoma (BCAC) of the supraglottic larynx. Pathology revealed a stage IVA tumor, pathological stage T4N0M0. She was treated with surgery and did not receive any adjuvant chemotherapy or radiation therapy. At the age of 93, during a routine examination, the patient was found to have palpable adenopathy and underwent a fine needle aspiration in June 2010. Pathology revealed similar histologic characteristics of her 2001 BCAC diagnosis, and further IHC stains revealed positive estrogen receptor staining.